FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: PRESCRIPTION DRUG USER FEE ACT VII; INDEPENDENT ASSESSMENT OF COMMUNICATION THROUGH PRODUCT QUALITY INFORMATION REQUESTS DURING APPLICATION REVIEW; FINAL REPORT; AVAILABILITY; REOPENING OF COMMENT PERIOD

WASHINGTON, Aug. 4 -- Food and Drug Administration has issued a notice called: Prescription Drug User Fee Act VII; Independent Assessment of Communication Through Product Quality Information Requests During Application Review; Final Report; Availability; Reopening of Comment Period.

The notice was published in the Federal Register on Aug. 4 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the notice of availability entitled "Prescription Drug User Fee Act VII; Independent Assessment of Communication Through Product Quality Information Requests During Application Review; Final Report; Availability; Re...